Cargando…

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

BACKGROUND/AIM: Dopamine supersensitivity psychosis (DSP), clinically characterized by unstable and severe psychosis or tardive dyskinesia and often categorized as treatment-resistant schizophrenia, is promoted by long-term antipsychotic treatment. An upregulation of the dopamine D(2) receptor cause...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oda, Yasunori, Kanahara, Nobuhisa, Kimura, Hiroshi, Watanabe, Hiroyuki, Hashimoto, Kenji, Iyo, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524575/ https://www.ncbi.nlm.nih.gov/pubmed/26251601 http://dx.doi.org/10.2147/NDT.S86042

Ejemplares similares

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
por: Oda, Yasunori, et al.
Publicado: (2015)

Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia
por: Kanahara, Nobuhisa, et al.
Publicado: (2021)

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
por: Tadokoro, Shigenori, et al.
Publicado: (2012)

Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases
por: Kanahara, Nobuhisa, et al.
Publicado: (2023)

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
por: Tadokoro, Shigenori, et al.
Publicado: (2017)

Successful rechallenge with paliperidone after clozapine treatment for a patient with dopamine supersensitivity psychosis
por: Kobayashi, Remiko, et al.
Publicado: (2020)

An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2015)

Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder
por: Tadokoro, Shigenori, et al.
Publicado: (2011)

Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine
por: Takao, Nagara, et al.
Publicado: (2021)

First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort
por: Kanahara, Nobuhisa, et al.
Publicado: (2018)

PM429. Comparison of haloperidol and blonanserin on development of dopamine supersensitivity after chronic treatment
por: Hashimoto, Takashi, et al.
Publicado: (2016)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia
por: Oishi, Kengo, et al.
Publicado: (2018)

Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
por: Yin, John, et al.
Publicado: (2017)

Autistic traits and cognitive profiles of treatment-resistant schizophrenia()
por: Nakata, Yusuke, et al.
Publicado: (2020)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
por: Hashimoto, Tasuku, et al.
Publicado: (2015)

Onset Pattern and Long-Term Prognosis in Schizophrenia: 10-Year Longitudinal Follow-Up Study
por: Kanahara, Nobuhisa, et al.
Publicado: (2013)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group
por: Sasaki, Tsuyoshi, et al.
Publicado: (2016)

Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case–Control Study
por: Yamamoto, Tetsuya, et al.
Publicado: (2021)

Supersensitivity Psychosis and Its Response to Asenapine in a Patient with Delusional Disorder
por: Rajkumar, Ravi Philip
Publicado: (2014)

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
por: Hagiwara, Hiroko, et al.
Publicado: (2013)

PM365. Effects of sulforaphane in the maternal immune activation model of schizophrenia
por: Matsuura, Akiko, et al.
Publicado: (2016)

Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
por: Burström, Viktor, et al.
Publicado: (2023)

Limonene Inhibits Methamphetamine-Induced Sensitizations via the Regulation of Dopamine Receptor Supersensitivity
por: Gu, Sun Mi, et al.
Publicado: (2019)

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia
por: Ma, Chia-Hao, et al.
Publicado: (2022)

Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases
por: Muneoka, Katsumasa, et al.
Publicado: (2017)

Supersensitive phospholipid sensing
por: LeBrasseur, Nicole
Publicado: (2005)

Supersensitiveness to Serum-Injections
Publicado: (1909)

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
por: Sasaki, Tsuyoshi, et al.
Publicado: (2014)

Supersensitivity Following Lesions of the Nervous System
por: Flanigan, Stevenson
Publicado: (1962)

Supersensitive Detector of Hydrosphere Pressure Variations
por: Dolgikh, Grigory, et al.
Publicado: (2020)

Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens
por: Rose, Jamie H., et al.
Publicado: (2015)

Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects
por: Fukami, Goro, et al.
Publicado: (2010)

Supersensitive Worms Reveal New Gene Functions
Publicado: (2003)

Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
por: Matsuura, Akiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_398mkvirdt2oeb67up0blucr1l